CN Patent
CN106699637A — 一种匹马色林单酒石酸盐晶型及其制备方法
Assigned to Chongqing Pharmaceutical Research Institute Co Ltd · Expires 2017-05-24 · 9y expired
What this patent protects
本发明涉及一种匹马色林单酒石酸盐晶型，其X粉末衍射图的2θ值在6.86±0.2°、14.92±0.2°、18.12±0.2°、19.98±0.2°和20.32±0.2°处有特征衍射峰。该晶型的制备方法包括将匹马色林单酒石酸盐悬浮在非质子溶剂中，搅拌、析晶，分离出晶型。该晶型稳定，适合制剂的制造和生产。
USPTO Abstract
本发明涉及一种匹马色林单酒石酸盐晶型，其X粉末衍射图的2θ值在6.86±0.2°、14.92±0.2°、18.12±0.2°、19.98±0.2°和20.32±0.2°处有特征衍射峰。该晶型的制备方法包括将匹马色林单酒石酸盐悬浮在非质子溶剂中，搅拌、析晶，分离出晶型。该晶型稳定，适合制剂的制造和生产。
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.